RFK, Jr., Questions Safety of Approved RSV Shots for Babies
NeutralScience
- FDA officials are currently reassessing several approved therapies for treating RSV in infants, despite previous clinical trials indicating these shots were safe. This scrutiny arises amid ongoing public discussions about vaccine safety and efficacy, particularly concerning childhood vaccinations.
- The implications of this reassessment are significant, as it may affect public confidence in vaccines designed to protect vulnerable infants from RSV, a serious respiratory illness. Any changes in the FDA's stance could influence healthcare practices and parental decisions regarding vaccination.
- This development reflects broader concerns about vaccine safety and regulatory processes, particularly as the FDA contemplates changes to its vaccine approval protocols. Such changes could impact not only RSV vaccines but also those for other diseases like COVID-19 and influenza, raising questions about accessibility and safety in pediatric healthcare.
— via World Pulse Now AI Editorial System
